Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034

Description

Drugs of Abuse (DOA) testing refers to the process of detecting the presence of illicit substances or misused prescription medications in an individual's system. This testing is utilized by various entities, including employers, law enforcement agencies, healthcare providers and educational institutions, to ensure safety, compliance with regulations and to provide appropriate medical interventions.

The drugs of abuse (DOA) testing market consists of sales, by entities (organizations, sole traders, or partnerships), of drugs of abuse (DOA) testing software and services used in workplaces, law enforcement, healthcare and rehabilitation programs to identify drug use, ensure compliance with regulations and support medical or legal decisions.

The global drugs of abuse (DOA) testing market was valued at $5,393.40 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Drug Abuse Cases

The growth of the drugs of abuse testing market during the historic period has been driven by the rising drug abuse cases. Drug abuse cases refer to situations where individuals excessively or improperly use substances such as illegal drugs, prescription medications, or other harmful substances, leading to physical, psychological, or social harm. Increasing drug abuse cases are often associated with escalating mental health issues, as many individuals resort to substances like opioids or cannabis to cope with conditions such as anxiety, depression, or emotional distress. The demand for drugs of abuse testing is propelled by the need for monitoring, detection, and prevention of substance misuse by employers, healthcare providers, law enforcement agencies, and educational institutions to maintain safety, compliance, and public health. For example, according to the Office for National Statistics, a UK-based government department, approximately 9.5% of individuals aged 16 to 59 years (around 3.1 million people) reported using drugs in the year ending March 2023. Among them, 7.6% reported cannabis use (around 2.5 million people), while 3.3% reported using Class A drugs (about 1.1 million people). Therefore, the increasing prevalence of drug abuse cases has significantly contributed to the expansion of the drugs of abuse testing market.

Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency

Leading companies in the drugs of abuse testing market are focusing on developing innovative solutions, such as mass spec solutions, to enhance the accuracy, sensitivity, and speed of drug testing processes. Mass Spec solution in drugs of abuse testing refers to the use of mass spectrometry (MS) technology for detecting and quantifying drugs and their metabolites in various biological samples, such as blood, urine, saliva, and hair. For instance, in December 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its cobas Mass Spec solution, which has received CE mark approval, marking a significant milestone in making clinical mass spectrometry widely available. This solution includes the cobas i 601 analyzer and the first Ionify reagent pack, enabling automated and standardized testing for over 60 analytes, including steroid hormones, vitamin D metabolites, and drugs of abuse. By integrating various technologies into a single platform, Roche aims to enhance diagnostic accuracy and efficiency in routine laboratories, facilitating earlier detection of therapeutic changes in patients. The cobas Mass Spec solution is expected to transform clinical diagnostics by providing faster, more precise results, ultimately improving patient care worldwide.

The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023.

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product and service, by sample type, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product and service, by sample type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market- Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for drugs of abuse (DOA) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
2) By Sample Type: Urine; Hair; Oral Fluid; Breath; Other Sample Types
3) By Application: Pain Management; Criminal Justice; Workplace Screening
4) By End User: Hospitals; Diagnostics Laboratories; Forensic Laboratories; Other End Users
Companies Mentioned: Abbott Laboratories; Danaher Corporation (Beckman Coulter); Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Thermo Fisher Scientific Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drugs of abuse (DOA) testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1637

1 Executive Summary

1.1 Drugs Of Abuse (DOA) Testing - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Drugs Of Abuse (DOA) Testing Market Definition And Segmentations
6.4 Market Segmentation By Product And Service
- 6.4.1 Analyzers
- 6.4.2 Rapid Testing Devices
- 6.4.3 Consumables
- 6.4.4 Laboratory Services
6.5 Market Segmentation By Sample Type
- 6.5.1 Urine
- 6.5.2 Hair
- 6.5.3 Oral Fluid
- 6.5.4 Breath
- 6.5.5 Other Sample Types
6.6 Market Segmentation By Application
- 6.6.1 Pain Management
- 6.6.2 Criminal Justice
- 6.6.3 Workplace Screening
6.7 Market Segmentation By End-User
- 6.7.1 Hospitals
- 6.7.2 Diagnostic Laboratories
- 6.7.3 Forensic Laboratories
- 6.7.4 Other End-Users

7 Major Market Trends

7.1 Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency
7.2 Innovative Drugs Of Abuse Reagents Enhance Accuracy And Portability In Testing
7.3 Expansion Of Urine Drugs Of Abuse Testing For Enhanced Accuracy And Rapid Detection

8 Global Drugs Of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

8.1 Global Drugs Of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End-Users (B2B)
- 8.2.1 Hospitals
- 8.2.2 Diagnostic Laboratories
- 8.2.3 Forensic Laboratories
- 8.2.4 Other End-Users
8.3 Global Drugs Of Abuse (DOA) Testing Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
- 8.5.1 Market Drivers 2024 - 2029
- 8.5.2 Market Restraints 2024 - 2029
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Drugs Of Abuse (DOA) Testing Total Addressable Market (TAM)

9 Global Drugs Of Abuse (DOA) Testing Market Segmentation

9.1 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Drugs Of Abuse (DOA) Testing Market, Regional and Country Analysis

10.1 Global Drugs Of Abuse (DOA) Testing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Drugs Of Abuse (DOA) Testing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Drugs Of Abuse (DOA) Testing Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Major Companies
11.10 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Major Companies
11.34 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
12.7 UK Market
12.8 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis
13.7 Russia Market
13.8 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Drugs Of Abuse (DOA) Testing Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Drugs Of Abuse (DOA) Testing Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Abbott Laboratories
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Financial Overview
18.3 Danaher Corporation (Beckman Coulter)
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Financial Overview
18.4 Laboratory Corporation of America Holdings
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Financial Overview
18.5 Quest Diagnostics Inc.
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Thermo Fisher Scientific Inc.
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 F. Hoffmann-La Roche Ltd.
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Dragerwerk AG & Co. KGaA
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Siemens Healthneers
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 Bio-Rad Laboratories Inc.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Agilent Technologies Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 HireRight Holdings Corporation.
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Sonic Healthcare Limited
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 LGC Limited
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 DISA Global Solutions Inc.
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Randox Laboratories Ltd.
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Intoximeters Inc.
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 First Advantage Corporation
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Cordant Health Solutions
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Precision Diagnostics LLC
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Omega Laboratories Inc.
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Premier Biotech Inc., Acquired Desert Tox LLC
22.2 Aegis Sciences Corporation Acquires Healthtrackrx's Toxicology Business

23 Recent Developments in the Drugs of Abuse Testing Market

23.1 Dual Blood Marker Test Launched For Enhanced Alcohol Monitoring

24 Opportunities And Strategies

24.1 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Drugs Of Abuse (DOA) Testing Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Drugs Of Abuse (DOA) Testing Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer